Navigation Links
NIH awards Rice $1.7M for cartilage-regeneration research

HOUSTON -- (July 19, 2010) -- Bioengineers from Rice University's BioScience Research Collaborative have won a $1.7 million grant from the National Institutes of Health to develop an injectable mix of polymers and adult stem cells that can spur the growth of new cartilage in injured knees and other joints.

"Millions of people live with pain, limited mobility and arthritis that often result from cartilage injuries, particularly those to the knee," said Rice researcher Kurt Kasper, a principal investigator on the new five-year grant. "By combining just enough of a patient's own stem cells with the proper mix of growth factors and polymers, we hope to allow the body to do something it cannot normally do -- fill in small gaps with healthy, new bone-protecting cartilage."

The research lies at the cutting-edge of basic science and engineering, and Kasper said a human treatment, if it proves feasible, would still be at least a decade away.

In joints like the knee, elbow and shoulder, a thin layer of cartilage covers and protects the bones at the point where they meet and rotate against one another. This "articular" cartilage is one of many types of cartilage found in the body, and it has wondrous material properties. For example, it's so impact-resistant and resilient that no currently available synthetic materials can stand up to the punishment it endures.

Because no synthetics can suitably replace articular cartilage, and because the body has almost no natural ability to repair it, Kasper and other researchers are looking for ways to reinforce and expand upon the healing abilities the body already has.

Rice's research team on the new project includes Kasper, a faculty fellow in the Department of Bioengineering, and Antonios Mikos, the Louis Calder Professor of Bioengineering, professor in chemical and biomolecular engineering and director of Rice's Center for Excellence in Tissue Engineering.

The team will use mesenchymal stem cells (MSCs), a type of stem cell that the body uses naturally to repair broken bones, injured skin and other tissues. Researchers have long known that MSCs can be coaxed into becoming cartilage-generating cells with the right combination of growth factors.

"We aim to find the optimal formulation of MSCs and growth factors for regenerating articular cartilage," Mikos said. "We will deliver that mix in a nontoxic, biodegradable polymer system that can be injected as a liquid and that gels quickly to form a temporary support matrix to guide the growth of the new cartilage."

Kasper said a unique aspect of the study is its focus on developing techniques that will allow the newly formed cartilage to attach naturally to the underlying bone in the joint. To do this, the team hopes to develop a two-layered system where the upper layer of articular cartilage is grown atop a segment of newly formed bone. A different formulation of growth factors and MSCs will be needed in each layer, and tests in animals will be used to determine the optimal mix that might be needed for future clinical translation to humans.

Contact: Jade Boyd
Rice University

Related biology news :

1. NIH doles out $3M in new innovator awards to 2 UC San Diego faculty
2. NIH awards Clemson bioengineer $1.5 million to improve durability of tissue heart valves
3. Entertainment Software Association Foundation awards grant to FAS for immune attack
4. Audience Selected as Silver Winner in This Years Wall Street Journal Technology Innovation Awards and Winner of the Semiconductors Category
5. NIAID announces 25 new awards to develop radiation countermeasures
6. Human Microbiome Project awards funds for technology development, data analysis and ethical research
7. University success at national engineering awards
8. New Systems Biology Awards enable detailed study of microbes
9. Soil Science Society of America presents awards in Houston
10. ASU researchers receive NIH awards for studies of malaria and emergent disease
11. NIH funds 16 Science Education Partnership Awards
Post Your Comments:
(Date:11/17/2015)... , November 17, 2015 ... au 19 novembre  2015.  --> Paris ... --> DERMALOG, le leader de l,innovation biométrique, ... la fois passeports et empreintes sur la même surface ... les passeports et l,autre pour les empreintes digitales. Désormais, ...
(Date:11/12/2015)... 12, 2015  A golden retriever that stayed healthy ... (DMD) has provided a new lead for treating this ... Broad Institute of MIT and Harvard and the University ... Cell, pinpoints a protective gene ... disease,s effects. The Boston Children,s lab of Lou ...
(Date:11/10/2015)... , Nov. 10, 2015  In ... on the basis of product, type, application, ... included in this report are consumables, services, ... report are safety biomarkers, efficacy biomarkers, and ... this report are diagnostics development, drug discovery ...
Breaking Biology News(10 mins):
(Date:11/25/2015)... 26, 2015 --> ... 2016 - 2020 report analyzes that automating biobanking ... quality in long-term samples, minimizing manual errors, improving ... minimizes manual errors such as mislabeling or inaccurate ... it plays a vital role in blood fractionation, ...
(Date:11/25/2015)... , November 25, 2015 2 ... première fois les différences entre les souches bactériennes ... celles des êtres humains . Ces recherches ... et envisager la prise en charge efficace de ... diagnostiqués chez les chats .    --> ...
(Date:11/25/2015)... HOLLISTON, Mass. , Nov. 25, 2015 ... a biotechnology company developing bioengineered organ implants for life-threatening ... will present at the LD Micro "Main Event" investor ... PT. The presentation will be webcast live and posted ... also be available at the conference for one-on-one meetings ...
(Date:11/25/2015)... QUEBEC CITY , Nov. 25, 2015 /PRNewswire/ ... "Company"), affirms that its business and prospects remain ... , Zoptrex™ (zoptarelin doxorubicin) recently received DSMB ... program to completion following review of the final ... met Phase 2 Primary Endpoint in men with ...
Breaking Biology Technology: